The POLE variant seen in our patient, P436R, has been documented in a handful of endometrial and colon cancer cases and has been described to have a high MutationAssessor-predicted functional impact score (MASS PIFS) and a damaging effect on other predicted functional impact scores [21,37,38]. This evidence concerns the gene POLE and colonic neoplasm.